Jefferies analyst, Hugo Ong, reiterated his Buy rating for AcelRx Pharmaceuticals (NASDAQ: ACRX), after conducting a proprietary Emergency Dept physician ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE